Moreover, studies have indicated that inhibitors of EPHX2 can accelerate the progression of melanoma and fibrosarcoma in murine models by augmenting levels of the endogenous lipid mediator epoxyeicosatrienoic acid (EET), further implicating EPHX2 in lipid metabolism and tumor progression (25). The gene discussed is EPHX2; the disease is melanoma.